IU School of Dentistry Makes Gel to Improve Root Canals

Posted: Updated:
Yassen says his gel protects stem cells that conventional solutions destroy. Yassen says his gel protects stem cells that conventional solutions destroy.

Just the thought of a root canal makes many shudder, but perhaps even more terrifying is a repeat root canal if the first one wasn’t effective. A researcher with the Indiana University School of Dentistry says he’s developed a gel that could increase the effectiveness of root canals. Visiting Assistant Professor Dr. Ghaeth Yassen believes his antimicrobial gel is significantly better than conventional alternatives and even encourages the tooth to rebuilt itself—a critical factor for the youngest patients.

A root canal is a treatment to repair and save a badly damaged, decayed               or infected tooth; the term comes from the cleaning of the canals inside the tooth’s root. The process involves removing the middle part (or pulp) of the tooth, which contains nerves and blood vessels, because it’s infected or damaged. The dentist uses files to shape the empty canal, then washes out the chamber with an antimicrobial solution to kill any remaining bacteria, reducing the risk for further infection.

Yassen says, traditionally, dentists use a commercially available solution called calcium hydroxide or simply mix antibiotics with water to flush the chamber. This is the final step before they put the permanent material in place.

“These antibacterial materials [used to wash the chamber] only protect against bacteria the moment you apply them,” says Yassen. “They’re done as soon as you remove them.”

Yassen has developed an antibacterial gel to replace the traditional solutions; he says the gel binds to the tooth, providing up to four weeks of bacteria-killing power even after it’s washed out.

“Once you remove the gel, the effect of the gel is still there, because it binds to the hard tissue in the root and can be released over time,” says Yassen. “It can kill most of the bacteria in the root canal, which is important to keep the tooth from becoming infected again.” 

Yassen notes his gel also resolves a second problem with conventional antibacterial solutions. The roots of the tooth contain stem cells that can help a tooth regenerate, but Yassen says traditional bacteria-killing solutions also kill these stem cells.

“We want to preserve [these cells], so the root of the tooth can regenerate,” says Yassen. “My gel is very cell-friendly. We’ve done a lot of studies to identify a concentration that can still kill most of the microorganisms, but at the same time, maintain and preserve the cells in the root. If we can maintain their vitality, if we do not hurt these cells, they can continue to regenerate and form part of the root—kind of make the tooth mature again.”

Yassen, who is a pediatric dentist, says the gel would be especially valuable for young patients. He’s treated many kids who have fallen and damaged their adult tooth. When this happens, the pulp of the tooth dies, but the roots aren’t yet mature. Removing the tooth or putting in an implant aren’t options, because the kids are still developing and growing. The only remaining option is a root canal.

“It’s very challenging, because the apex of the tooth is not fully mature yet. [My gel] allows some of the stem cells that are in the root canal of these kids to stay alive and hopefully regenerate a little bit—specifically with kids, when the tooth is immature. It’s basically a complete formation after the tooth becomes dead,” says Yassen. “I’ve treated these [trauma] cases for years and years, so I know how hard it can be. I want to find something that can help in these cases.”

Yassen is working with the IU Innovation and Commercialization Office to move his technology to the market. He says U.S. Food and Drug Administration approval should be swift, because the individual components of the gel are FDA-approved. A patent is pending on the technology, and Yassen believes a commercial partner is the best route to take it to the next level.

Yassen is now poised for a human clinical trial to move his discovery to patients who could take some comfort in the dentist’s chair knowing their first root canal may stand a better chance of being their last.

Yassen says the gel will be opaque, so it is visible on X-rays to guide its placement.
While Yassen designed the gel with young patients in mind, he says it could be tailored to benefit different patients.
  • Perspectives

    • The Evolution of Business: From Bottom Line to Value Creation And Impact

      In today's world, consumers want to know how corporations, as a whole, are taking a stand. In fact, customers are 43 percent more likely to purchase a product from a company they know is committed to social value. It's not just consumers pushing this trend. Financial service industry leaders, like KeyBank's Beth Mooney and BlackRock's Larry Fink, are challenging business owners and the C-Suite to rethink their economic impact, environmental footprint and social conscience.

    More

Subscribe

Name:
Company Name:
Email:
Confirm Email:
HTML
INside Edge
Morning Briefing
BigWigs & New Gigs
Life Sciences Indiana
Indiana Connections
INPower
Subscribe
Unsubscribe

Events



  • Most Popular Stories

    • Indy Firm Taps Appirio Exec as CEO

      An Indianapolis-based design and innovation consulting firm has named a new chief executive officer. Studio Science says Steve Pruden, who most recently served as senior vice president of human resources with Indy tech company Appirio, will lead the company.

    • (Image Courtesy: Lilly Oncology)

      Lilly Closes on Mega Acquisition

      Indianapolis-based Eli Lilly and Co. (NYSE: LLY) has completed its acquisition of ARMO BioSciences Inc. of California. The deal, which was valued at approximately $1.6 billion when first announced last month, boosts Lilly's immuno-oncology pipeline. Lilly offered $50 per share of ARMO stock for the company. ARMO's portfolio includes...

    • Court Sides With Lilly on Alimta Case

      The latest in a string of patent infringement cases involving Indianapolis-based Eli Lilly and Co. (NYSE: LLY) has ended positively for the pharmaceutical giant. The U.S. District Court for the Southern District of Indiana has ruled in favor of Lilly, preventing a competitor from launching an alternative form of its Alimta vitamin regimen. The court ruled that Lilly's patent for Alimta would be infringed upon if India-based Dr. Reddy's Laboratories had moved forward with...

    • St. Vincent Announces Layoffs

      St. Vincent Health says it has laid off 85 employees throughout the state. In a statement to Inside INdiana Business, St. Vincent cites a rapidly-evolving healthcare environment as a reason for the workforce reduction. 

    • Pam Austin

      PNC Bank Appoints Senior VP

      PNC Bank has appointed Pamela Austin senior vice president and senior banking advisor for wealth management. She has more than 30 years of banking experience, including private banking, financial analysis, marketing, business development sales, wealth transfer and problem resolution for clients and their families. Most recently she served as vice president at 1st Source Bank.